Revenue: As of FY2025 Q1, the actual value is USD 27.63 M.EPS: As of FY2025 Q1, the actual value is USD -0.04.EBIT: As of FY2025 Q1, the actual value is USD 1.989 M.<h3>Healthcare IT Segment</h3><ul><li>Net Revenue: $24,643,000 for the three months ended March 31, 2025, compared to $22,721,000 for the same period in 2024.</li><li>Operating Expenses: Direct operating costs were $12,904,000, selling and marketing expenses were $1,124,000, general and administrative expenses were $2,112,000, research and development expenses were $1,235,000, and depreciation and amortization were $3,255,000 for the three months ended March 31, 2025.</li><li>Operating Income: $3,899,000 for the three months ended March 31, 2025, compared to $756,000 for the same period in 2024.</li></ul><h3>Medical Practice Management Segment</h3><ul><li>Net Revenue: $2,989,000 for the three months ended March 31, 2025, compared to $3,241,000 for the same period in 2024.</li><li>Operating Expenses: Direct operating costs were $2,560,000, selling and marketing expenses were $7,000, general and administrative expenses were $642,000, and depreciation and amortization were $82,000 for the three months ended March 31, 2025.</li><li>Operating Loss: -$302,000 for the three months ended March 31, 2025, compared to $79,000 operating income for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $5,113,000 for the three months ended March 31, 2025, compared to $4,066,000 for the same period in 2024.</li><li>Net Cash Used in Investing Activities: -$1,510,000 for the three months ended March 31, 2025, compared to -$1,868,000 for the same period in 2024.</li><li>Net Cash Used in Financing Activities: -$1,932,000 for the three months ended March 31, 2025, compared to -$1,374,000 for the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to continue enhancing its liquidity and financial position by managing expenses and growing revenue, with a focus on overall profitability.</li><li>Non-Core Business: The company completed an acquisition of an audiology-focused revenue cycle management company in April 2025, with consideration to be paid over the next 3.5 years based on collected revenue.</li></ul>

Carecloud Pref Share CCLDO 8.75 Prep 02/15/24 B | 10-Q: FY2025 Q1 Revenue: USD 27.63 M